Unknown

Dataset Information

0

Obesity dysregulates fasting-induced changes in glucagon secretion.


ABSTRACT: Hyperglucagonemia, a hallmark in obesity and insulin resistance promotes hepatic glucose output, exacerbating hyperglycemia and thus predisposing to the development type 2 diabetes. As such, glucagon signaling is a key target for new therapeutics to manage insulin resistance. We evaluated glucagon homeostasis in lean and obese mice and people. In lean mice, fasting for 24 h caused a rise in glucagon. In contrast, a decrease in serum glucagon compared to baseline was observed in diet-induced obese mice between 8 and 24 h of fasting. Fasting decreased serum insulin in both lean and obese mice. Accordingly, the glucagon:insulin ratio was unaffected by fasting in obese mice but increased in lean mice. Re-feeding (2 h) restored hyperglucagonemia in obese mice. Pancreatic perfusion studies confirm that fasting (16 h) decreases pancreatic glucagon secretion in obese mice. Consistent with our findings in the mouse, a mixed meal increased serum glucagon and insulin concentrations in obese humans, both of which decreased with time after a meal. Consequently, fasting and re-feeding less robustly affected glucagon:insulin ratios in obese compared to lean participants. The glucoregulatory disturbance in obesity may be driven by inappropriate regulation of glucagon by fasting and a static glucagon:insulin ratio.

SUBMITTER: Stern JH 

PROVIDER: S-EPMC6994388 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Obesity dysregulates fasting-induced changes in glucagon secretion.

Stern Jennifer H JH   Smith Gordon I GI   Chen Shiuwei S   Unger Roger H RH   Klein Samuel S   Scherer Philipp E PE  

The Journal of endocrinology 20191101 2


Hyperglucagonemia, a hallmark in obesity and insulin resistance promotes hepatic glucose output, exacerbating hyperglycemia and thus predisposing to the development type 2 diabetes. As such, glucagon signaling is a key target for new therapeutics to manage insulin resistance. We evaluated glucagon homeostasis in lean and obese mice and people. In lean mice, fasting for 24 h caused a rise in glucagon. In contrast, a decrease in serum glucagon compared to baseline was observed in diet-induced obes  ...[more]

Similar Datasets

| S-EPMC2696192 | biostudies-literature
| S-EPMC6014553 | biostudies-literature
| S-EPMC1217800 | biostudies-other
| S-EPMC7184883 | biostudies-literature
2022-05-06 | E-MTAB-11551 | biostudies-arrayexpress
| S-EPMC6370947 | biostudies-literature
| S-EPMC6086569 | biostudies-literature
| S-EPMC3636632 | biostudies-literature
2022-10-26 | GSE179894 | GEO
2022-05-06 | E-MTAB-11538 | biostudies-arrayexpress